Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Prathima Reddy"'
Publikováno v:
Education Sciences, Vol 11, Iss 3, p 111 (2021)
In response to international agreements, recent Indian legislation has raised expectations that all children, regardless of need or ability, should gain access to formal education that is inclusive and addresses their social and learning needs. Initi
Externí odkaz:
https://doaj.org/article/06a23675ee4941069399e1ffdfaa72d1
Autor:
Pradeep Battula, B. Prathima Reddy, L. Poonam, L. Hemanth Kumar, N. Dimpu Sri, Kali Chandra Shekar
Publikováno v:
Current Overview on Pharmaceutical Science Vol. 5 ISBN: 9788119039555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7101c2cb91c3880714c77b43a1cf098b
https://doi.org/10.9734/bpi/cops/v5/18026d
https://doi.org/10.9734/bpi/cops/v5/18026d
Autor:
Melody R. Becnel, Andrew M. Evens, Stephen D. Smith, Pooja Mehra, Amrita Desai, Prathima Reddy, Dhruvika Mukhija, Max L. Goldman, Bita Fakhri, James R. Cerhan, Brad S. Kahl, Abhigna Kodali, Jonathon B. Cohen, Brian K. Link, Juan Pablo Alderuccio, Deepa Jagadeesh, Nilanjan Ghosh, Allison M. Winter, Izidore S. Lossos, Thomas M. Habermann, Mohammad Junaid Hussain, Oscar Calzada, Timothy Tiutan, Peter Martin, Loretta J. Nastoupil, Craig A. Portell, Matthew J. Maurer, Brian T. Hill, Paolo Caimi
Publikováno v:
British journal of haematology, vol 184, iss 4
Bendamustine (B) with rituximab (R) is a standard frontline treatment for medically fit follicular lymphoma (FL) patients. The safety and efficacy of maintenance rituximab (MR) after BR induction has not been formally compared to observation for FL,
Publikováno v:
Education Sciences
Volume 11
Issue 3
Education Sciences, Vol 11, Iss 111, p 111 (2021)
Volume 11
Issue 3
Education Sciences, Vol 11, Iss 111, p 111 (2021)
In response to international agreements, recent Indian legislation has raised expectations that all children, regardless of need or ability, should gain access to formal education that is inclusive and addresses their social and learning needs. Initi
Autor:
Oliver W. Press, Houston Warren, Mazyar Shadman, Brian G. Till, Stephen D. Smith, Andrei R. Shustov, Prathima Reddy, Ajay K. Gopal, Ryan D. Cassaday, Andrew J. Cowan, Sandra Kanan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:e87-e90
Introduction Infusional da-EPOCH-R (dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine, prednisone, and rituximab) is a dose-intensified regimen with a potential role in treating high-risk subtypes of aggressive B-cell non-Ho
Autor:
Brian G. Till, Shruti Gandhy, Brian T. Hill, Lauren Low, Stephen D. Smith, Ryan C. Lynch, Sandra Kanan, Andrew J. Cowan, Prathima Reddy, Mazyar Shadman, Ajay K. Gopal
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(1)
Background Initial treatment of mantle cell lymphoma (MCL) incorporating autologous stem cell transplantation affords long-term remissions, but relapses still occur. Optimal pretransplant therapy will afford high complete response rates and not impai
Autor:
Juan Pablo Alderuccio, Abhigna Kodali, Brian T. Hill, Pooja Mehra, Max L. Goldman, Adam Kittai, Timothy Tiutan, Christopher D'Angelo, Manali Kamdar, Peter Martin, James R. Cerhan, Andrew M. Evens, Prathima Reddy, Dhruvika Mukhija, Amrita Desai, Melody R. Becnel, Paolo Caimi, Matthew J. Maurer, Craig A. Portell, Stephen D. Smith, Alexey V. Danilov, Yang Liu, Allison M. Winter, Deepa Jagadeesh, Thomas M. Habermann, Izidore S. Lossos, Vaishalee P. Kenkre, Nathalie C Danielson, Loretta J. Nastoupil, Bita Fakhri, Nilanjan Ghosh, Mohammad Junaid Hussain, Oscar Calzada, Jonathon B. Cohen, Brian K. Link, Brad S. Kahl, Stefan K. Barta
Publikováno v:
Blood. 132:4146-4146
Background: Bendamustine and rituximab (BR) is a commonly chosen frontline treatment for grade 1-2 (G 1-2) follicular lymphoma (FL). This regimen resulted in significantly longer progression-free survival (PFS) and less toxicity compared to R-CHOP in
Autor:
Edus H. Warren, Alexandra O. Sokolova, Ajay K. Gopal, Mazyar Shadman, Manoj Menon, Yolanda D. Tseng, Andrei R. Shustov, Prathima Reddy, Stephen D. Smith, Sandra Kanan, Victor A. Chow, Brian G. Till, Ryan C. Lynch
Publikováno v:
Blood. 132:2911-2911
Background: Chemorefractory diffuse large B-cell lymphoma (DLBCL) is associated with poor outcomes. Recent Car-T therapy trials, including Zuma-1 which led to the first FDA approval of Car-T for DLBCL (Neelapu NEJM), have shown sustained complete rem
Autor:
Prathima Reddy
Publikováno v:
Severe Acute Maternal Morbidity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c1ea3afb36409c4f02718dc501061b3
https://doi.org/10.5005/jp/books/11332_24
https://doi.org/10.5005/jp/books/11332_24